Cheryl Clausen

FDA investigator · also recorded as Ph Pe Cheryl Clausen, Y. Cheryl Clausen

Appears on 18 documents from 2016 to 2020, mostly at sites in India. Most often cites responsibilities of quality control unit (21 CFR 211.22).

18
Documents on file
7.1
Observations per 483
2016
First seen
2020
Most recent

What they cite most

From 120 observations

Activity by year

2016: 2, 2017: 3, 2018: 6, 2019: 6, 2020: 1

Where

India 11 · Japan 4 · China 2 · South Africa 1

Is Cheryl Clausen coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

18 documents, newest first
FirmOpen
483 Daito Pharmaceutical Co., LtdJan 31, 2020 · Toyama-City, Japan
483 Sun Pharmaceutical Industries LimitedNov 8, 2019 · Bharuch, India
483 Chugai Pharma Manufacturing Co., LtdSep 26, 2019 · Utsunomiya, Japan
483 MicroBiopharm Japan Co., Ltd.Sep 13, 2019 · Iwata, Japan
483 Sun Pharmaceutical Industries LimitedMar 29, 2019 · Dadra, India
483 CIPLA LIMITEDMar 20, 2019 · Pune, India
483 Dr. Reddy's Laboratories Ltd. No 41 Quthbullapur MandalFeb 8, 2019 · Bachupally, India

About this profile

What does Cheryl Clausen inspect?

Cheryl Clausen appears on 18 documents on file covering 16 sites, mostly in India.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.160 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Cheryl Clausen is dated Jan 31, 2020.